StockData
Quest Diagnostics Inc logo

Quest Diagnostics Inc (DGX) income statement

DGXNYSEServices-Medical LaboratoriesFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 23, 2026Score 12/308% above fair value
$259.69+3.34 (+1.30%)

Close on Nov 18, 2026Market cap $28.57BP/E 25.9Yield –

Quest Diagnostics Inc income statement

Ratios

Latest available, balances at Sep 30, 2026

Profitability, TTM

Gross margin
33.1%
Operating margin
14.6%
Net margin
9.5%
Return on equity, FY2025
14.2%

Financial strength

Current ratio
1.70
Debt to equity
0.73
Debt to assets
32.2%
Cash to current liabilities
43.5%

Valuation

P/E ratio
25.9
Price to sales
2.41
Price to book
3.74
Dividend yield
–

See a number that looks wrong?